Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP], Ventilator-associated Pneumonia [VAP]), By Type (Drugs, Preventive Vaccines, Oxygen Therapy), By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) Region and Competition

Published	Pages	Publisher	Report code
Feb 2024	184	TechSci Research	ASDR-657648

Published: Feb 2024 - Pages : 184 - Publisher : TechSci Research - Report code : ASDR-657648

1. Pfizer Inc.
2. AstraZeneca Plc.
3. Eli Lilly & company
4. F. Hoffmann-La Roche Ltd.
5. Viatris Inc.
6. Teva Pharmaceutical Industries Ltd.
7. Sanofi SA
8. Novartis AG
9. Sun Pharmaceutical Industries Ltd.
10. Aurobindo Pharma

Pneumonia Therapeutics - Global Forecast 2024-2030

This report can be of interest as well:

Pneumonia Therapeutics - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-651607